Get started
Work

Figure 2 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy

Year: 2025
Type: other
Abstract: Ferroptosis complements liver metastasis and TMB to predict immunotherapy outcomes. A, OS analysis of patients based on the status of liver metastasis and ferroptosis in tumor tissue in the IMvigor210 cohort. B, OS analysis of patients based on the status of liver metastasis and ferroptosis in tumor tissue in the Liu cohort. C, OS analysis of patients based on TMB and ferroptosis in tumor tissue in the IMvigor210 cohort. D, OS analysis of patients based on TMB and ferroptosis in tumor tissue in the Liu cohort. The log-rank test was applied for the survival analysis.
DOI: 10.1158/2767-9764.29836678
Authors: Zhijun Zhou, Yang Cai, Hao Yuan, Qun Chen, Sophia W. Zhao, Jingxuan Yang, Mingyang Liu, Alex X. Arreola, Yu Ren, Chao Xu, Lacey R. McNally, Michael S. Bronze, Courtney W. Houchen, Kuirong Jiang, Wei R. Chen, Yuqing Zhang, Min Li
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4413005377
Cites:
Cited by:
Related to: 10